| Financial Year |
March 31 2023 |
| Monetary Funds |
64,116,446.14 |
| Held-for-trading Financial Assets |
312,607.99 |
| Notes Receivable |
14,173,094.72 |
| Accounts Receivable |
55,140,711.45 |
| Advances to Suppliers |
4,801,720.29 |
| Other Receivables |
2,299,530.71 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
132,813,642.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
1,431,325.10 |
| Total Current Assets |
291,563,692.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
6,020,842.46 |
| Investment Properties |
-- |
| Fixed Assetes |
17,519,317.65 |
| Under-construction Projects |
6,258,217.29 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,594,804.65 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,859,667.95 |
| Deferred Income Tax Assets |
11,056,454.10 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
70,517,935.05 |
| Total Assets |
362,081,627.18 |
| Short-Term Loans |
30,028,333.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
42,085,167.49 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
2,221,030.29 |
| Taxes Payable |
2,885,589.06 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,173,456.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,131,139.90 |
| Other Current Liabilities |
14,130,704.97 |
| Sub-Total of Current Liabilities |
158,389,975.02 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
7,781,197.07 |
| Total Liabilities |
166,171,172.09 |
| Paid-In Capital(Or Share Stock) |
143,448,332.00 |
| Capital Surplus |
3,963,157.99 |
| Surplus Reserve |
16,872,387.09 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-10,258,445.72 |
| Minority Stockholder's Interest |
41,708,484.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
154,201,970.38 |
| Owner's Equity（Stockholder's Equity） |
195,910,455.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
362,081,627.18 |
